1. Home
  2. IBN vs SNY Comparison

IBN vs SNY Comparison

Compare IBN & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICICI Bank Limited

IBN

ICICI Bank Limited

HOLD

Current Price

$30.90

Market Cap

107.0B

Sector

Finance

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$48.20

Market Cap

119.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBN
SNY
Founded
1955
1994
Country
India
France
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.0B
119.4B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
IBN
SNY
Price
$30.90
$48.20
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$61.50
AVG Volume (30 Days)
4.9M
2.3M
Earning Date
01-26-2026
01-29-2026
Dividend Yield
0.70%
3.37%
EPS Growth
11.76
105.93
EPS
0.83
8.67
Revenue
$21,493,768,246.00
$53,890,648,839.00
Revenue This Year
N/A
$1.73
Revenue Next Year
$13.50
$6.49
P/E Ratio
$18.12
$5.48
Revenue Growth
16.53
N/A
52 Week Low
$27.42
$44.62
52 Week High
$34.57
$60.12

Technical Indicators

Market Signals
Indicator
IBN
SNY
Relative Strength Index (RSI) 63.41 44.62
Support Level $29.64 $47.17
Resistance Level $30.20 $48.95
Average True Range (ATR) 0.26 0.54
MACD 0.09 0.03
Stochastic Oscillator 81.21 50.42

Price Performance

Historical Comparison
IBN
SNY

About IBN ICICI Bank Limited

ICICI Bank Ltd provides banking services. The company's operating segments include Retail Banking; Wholesale Banking; Treasury, Life insurance, Other Banking Business, and Others. The company generates maximum revenue from the Retail Banking segment which includes exposures of the Bank, which satisfy the four qualifying criteria of a regulatory retail portfolio as stipulated by RBI guidelines on the Basel III framework as well as includes income from credit cards, debit cards, third party product distribution, and the associated costs. Geographical segments include Domestic operations and Foreign operations. The company generates the majority of its revenue from the domestic operations.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: